4420 Rosewood Drive Suite 200 Pleasanton, CA 94588 astx.com
Note: Revenues for privately held companies are statistical evaluations.
Astex Pharmaceuticals's annual revenues are $100-$500 million (see exact revenue data) and has 100-500 employees. It is classified as operating in the Medicinal & Botanical Manufacturing industry.
Note: Astex Pharmaceuticals's revenues are gauged from an analysis of company filings.
Astex Pharmaceuticals's Income Statement (based on Industry Averages)
$ Millions (Industry Average)
Astex Pharmaceuticals Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Trademark Applications
Trademark applications show the products and services that Astex Pharmaceuticals is developing and marketing.
Astex Pharmaceuticals doesn't have any recent trademark applications, indicating Astex Pharmaceuticals is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
ASTEX Pharmaceuticals, namely, pharmaceutical preparations for the diagnosis or treatment of diseases and disorders, namely, oncological, neurological, dermatological, hematological, bone, respiratory, central nervous system, endrocrinological, circulatory, gastroenterological, hormonal and diabetic disorders, stomach and digestive disorders, muscular and/or rheumatic disorders, immune system disorders, allergic reactions, metabolic disorders, ocular disorders and pain; pharmaceuticals, namely, anti-inflammatory agents and anti-infectives
10/13/2011
A ASTEX PHARMACEUTICALS Providing health care information via the Internet
10/13/2011
DISCOVERING TOMORROW TODAY Providing information in the field of the diagnostic, prophylactic, and therapeutic properties of pharmaceuticals
04/12/2011
See all trademarks and details in the Full Report.
Recession Risk
Determine whether Astex Pharmaceuticals grew or shrank during the last recession. This is useful in estimating the
financial strength and credit risk of the company.
Compare how recession-proof Astex Pharmaceuticals is relative to the industry overall.
While a new recession may strike a particular industry, measuring the
industry and company's robustness during the last recession estimates its ability to weather future recessions.
Market Share of Astex Pharmaceuticals's Largest Competitors
A competitive analysis shows these companies are in the same general field as Astex Pharmaceuticals, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Astex Pharmaceuticals.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Astex Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.